CJC-1295 + Ipamorelin 5 mg + 5 mgConfezione da 10 flaconi6 disponibiliRisparmia il 22%
In evidenzapeptideintermediate6 disponibili

CJC-1295 + Ipamorelin 5 mg + 5 mg

Combinazione classica GHRH + mimetico della grelina

CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.

Dose
5mg + 5mg / flacone
Forma
Polvere liofilizzata
Confezione
Confezione da 10 flaconi

Solo per uso di ricerca. Questo composto è venduto strettamente per ricerca in vitro e scopi di laboratorio e non è destinato al consumo umano né a uso terapeutico. Acquistando, confermi di essere un ricercatore qualificato e accetti il nostro disclaimer completo.

186 € EUR
Risparmia il 22%
Confezione da 10 flaconi
Prima 238 € EUR
Venduto in confezione da 10 flaconi

Solo 6 confezioni rimaste

🧪Verificato in laboratorio
✓Analizzato da terzi
⚡Spedizione mondiale rapida
🔒Pagamento sicuro con carta
Panoramica

Flacone di ricerca combinato che abbina l’analogo GHRH CJC-1295 al mimetico selettivo della grelina Ipamorelin. La combinazione di secretagoghi del GH a doppio meccanismo più studiata nella ricerca sui peptidi.

CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.

Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.

Meccanismo

CJC-1295 sostiene la segnalazione basale del recettore GHRH, mentre Ipamorelin guida impulsi selettivi del recettore della grelina. La ricerca suggerisce pattern sinergici e naturalistici di rilascio di GH nei soggetti di studio.

Referto di laboratorio

Verificato in HPLC rispetto a una specifica di purezza ≥99 %. Testato in modo indipendente da laboratori terzi accreditati.

CJC-1295: DAC vs no-DAC

CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.

FAQ per i ricercatori

CJC-1295 + Ipamorelin — domande frequenti

What is the CJC-1295 + Ipamorelin stack?

It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.

How does CJC-1295 differ from Ipamorelin?

CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.

Is CJC-1295 + Ipamorelin legal in Australia?

Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.

What does selective mean for Ipamorelin?

Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.

What is the typical CJC-1295 + Ipamorelin research dosage?

Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

Are CJC-1295 and Ipamorelin used together?

Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.

Approfondimenti

Guide relative a CJC-1295 + Ipamorelin

Composti correlati

I ricercatori esplorano anche

TesamorelinConfezione da 10 flaconiRisparmia il 18%

Tesamorelin

Polvere liofilizzata

10 mg · 3 strengths

Analogo stabilizzato di GHRH

In 1 combinazione
352 € EUR
Risparmia il 18%
Confezione da 10 flaconi
Prima 430 € EUR
Vedi dettagli →
Melanotan IIIn evidenzaConfezione da 10 flaconiRisparmia il 22%

Melanotan II

Polvere liofilizzata

10 mg

Peptide di ricerca analogo di α-MSH

112 € EUR
Risparmia il 22%
Confezione da 10 flaconi
Prima 144 € EUR
Vedi dettagli →